fluocortolone has been researched along with bufexamac in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aertgeerts, P; Albring, M; Klaschka, F; Nasemann, T; Patzelt-Wenczler, R; Rauhut, K; Weigl, B | 1 |
| Macher, E; Vakilzadeh, F | 1 |
2 trial(s) available for fluocortolone and bufexamac
| Article | Year |
|---|---|
[Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous diseases].
Topics: Adolescent; Adult; Aged; Bufexamac; Chamomile; Clinical Trials as Topic; Dermatitis; Dermatitis, Contact; Dermatitis, Seborrheic; Diflucortolone; Female; Fluocortolone; Humans; Hydrocortisone; Hydroxamic Acids; Male; Middle Aged; Neurodermatitis; Oils, Volatile; Ointments; Plant Extracts; Plants, Medicinal | 1985 |
[Inflamed dermatoses. Treatment with Bufexamac. A randomized comparative double-blind study against fluocortinbutyl ester].
Topics: Adolescent; Adult; Aged; Bufexamac; Child; Child, Preschool; Clinical Trials as Topic; Dermatitis; Double-Blind Method; Fluocortolone; Humans; Hydroxamic Acids; Middle Aged; Random Allocation | 1983 |